MiR-124-3p has been shown to be vital for HDAC-mediated C-EBPα initiation in HCC (Hu et al., 2019) and may act as tumor-suppressor via targeting CBL in breast cancer (Wang et al., 2016a). Here, CBL is linked to breast cancer.